Evidence map›Paper›PMID 30018366›Full record

ArticleScientific reports2018

Involvement of leptin signaling in the development of cannabinoid CB2 receptor-dependent mirror image pain.

Chihiro Nozaki, Elisa Nent, Andras Bilkei-Gorzo, Andreas Zimmer

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Cannabinoid CBBritish journal of pharmacology · 2025
    Review
  2. Review
  3. Microglial Cannabinoid CBInternational journal of molecular sciences · 2023
    Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chihiro NozakiInstitute of Molecular Psychiatry, Medical Faculty, University of Bonn, 53127, Bonn, Germany.
Elisa NentInstitute of Molecular Psychiatry, Medical Faculty, University of Bonn, 53127, Bonn, Germany.
Andras Bilkei-GorzoInstitute of Molecular Psychiatry, Medical Faculty, University of Bonn, 53127, Bonn, Germany.
Andreas ZimmerInstitute of Molecular Psychiatry, Medical Faculty, University of Bonn, 53127, Bonn, Germany. neuro@uni-bonn.de.
University of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropathic pain typically appears in a region innervated by an injured or diseased nerve and, in some instances, also on the contralateral side. This so-called mirror image pain is often observed in mice lacking CB2 receptors after sciatic nerve injury, but the underlying mechanisms for this phenotype largely remain unclear. Here we focused on peripheral leptin signaling, which modulates neuropathic pain development and interacts with the endocannabinoid system. Leptin production is induced at the site of nerve injury in CB2-deficient mice (CB2-KO) mice and wild type controls (WT). However, induction of leptin receptor expression was only observed in the injured nerve of CB2-KO mice. This was paralleled by a stimulation of the leptin receptor-downstream STAT3 signaling and an infiltration of F4/80-positive macrophages. Interestingly, an upregulation of leptin receptor expression STAT3 activity and macrophage infiltration was also observed on the non-injured nerve of CB2-KO mice thus reflecting the mirror image pain in CB2-KO animals. Importantly, perineurally-administered leptin-neutralizing antibodies reduced mechanical hyperalgesia, blocked mirror image pain and inhibited the recruitment of F4/80-positive macrophages. These results identify peripheral leptin signaling as an important modulator of CB2 signaling in neuropathic pain.

Indexed as

AnimalsAntibodies, NeutralizingHyperalgesiaLeptinMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutNeuralgiaPeripheral Nerve InjuriesReceptor, Cannabinoid, CB2Receptors, LeptinSciatic NerveSignal TransductionSTAT3 Transcription FactorAntibodies, NeutralizingLeptinReceptor, Cannabinoid, CB2Receptors, LeptinSTAT3 Transcription Factor

Identifiers

PMID30018366
PMCPMC6050271
OpenAlexW2812581600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.